Regulation of Axonal Transport by Protein Kinases

Trends in Biochemical Sciences

Volumn 40, Issue 10, 2015, Pages 597-610

  Gibbs, Katherine L ^a   Greensmith, Linda ^a   Schiavo, Giampietro ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Axonal transport; Cytoplasmic dynein; Kinesin; Neurodegenerative diseases; Protein kinases

Indexed keywords

ADAPTOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CREATINE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; DYNEIN ADENOSINE TRIPHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3BETA; JANUS KINASE; KINESIN; KINESIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AXOPLASM; BINDING AFFINITY; CELL FUNCTION; CELL ORGANELLE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; ENDOSOME; ENZYME ACTIVATION; ENZYME INHIBITION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUNTINGTON CHOREA; INTRACELLULAR TRANSPORT; KENNEDY DISEASE; MICROTUBULE; MOLECULAR INTERACTION; MOTONEURON; NERVE CELL; NERVE FIBER TRANSPORT; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECYCLING; RETROGRADE NERVE FIBER TRANSPORT; REVIEW; SECRETORY VESICLE; SENSORY NERVE CELL; SYNAPSE VESICLE; CYTOPLASM; DEGENERATIVE DISEASE; HUMAN; METABOLISM; PHYSIOLOGY;

AXONAL TRANSPORT; CYTOPLASM; DYNEINS; HUMANS; MICROTUBULES; NEURODEGENERATIVE DISEASES; PROTEIN KINASES;

EID: 84942093939     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2015.08.003     Document Type: Review

References (110)

1. Schmieg N., et al. Signalling endosomes in axonal transport: travel updates on the molecular highway. Semin. Cell Dev. Biol. 2014, 27:32-43.
2. Matusica D., Coulson E.J. Local versus long-range neurotrophin receptor signalling: endosomes are not just carriers for axonal transport. Semin. Cell Dev. Biol. 2014, 31:57-63.
3. Doron-Mandel E., et al. Growth control mechanisms in neuronal regeneration. FEBS Lett. 2015, 589:1669-1677.
4. Rishal I., et al. A motor-driven mechanism for cell-length sensing. Cell Rep. 2012, 1:608-616.
5. Millecamps S., Julien J.P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 2013, 14:161-176.
6. Maday S., et al. Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron 2014, 84:292-309.
7. Kumar S., et al. Cytoplasmic dynein ATPase activity is regulated by dynactin-dependent phosphorylation. J. Biol. Chem. 2000, 275:31798-31804.
8. McIlvain J.M., et al. Regulation of kinesin activity by phosphorylation of kinesin-associated proteins. J. Biol. Chem. 1994, 269:19176-19182.
9. Seira O., Del Rio J.A. Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration. Mol. Neurobiol. 2014, 49:931-944.
10. Hetman M., Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur. J. Biochem. 2004, 271:2050-2055.
11. Coffey E.T. Nuclear and cytosolic JNK signalling in neurons. Nat. Rev. Neurosci. 2014, 15:285-299.
12. Kawauchi T. Cdk5 regulates multiple cellular events in neural development, function and disease. Dev. Growth Differ. 2014, 56:335-348.
13. Bilsland L.G., et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20523-20528.
14. Misgeld T., et al. Imaging axonal transport of mitochondria in vivo. Nat. Methods 2007, 4:559-561.
15. Hirokawa N., et al. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 2010, 68:610-638.
16. Vale R.D. The molecular motor toolbox for intracellular transport. Cell 2003, 112:467-480.
17. Castle M.J., et al. Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment. Mol. Ther. 2014, 22:554-566.
18. Brown C.L., et al. Kinesin-2 is a motor for late endosomes and lysosomes. Traffic 2005, 6:1114-1124.
19. Okada Y., et al. The activation of protein kinase A pathway selectively inhibits anterograde axonal transport of vesicles but not mitochondria transport or retrograde transport in vivo. J. Neurosci. 1995, 15:3053-3064.
20. Lo K.Y., et al. KIF1A is the primary anterograde motor protein required for the axonal transport of dense-core vesicles in cultured hippocampal neurons. Neurosci. Lett. 2011, 491:168-173.
21. Conde C., Caceres A. Microtubule assembly, organization and dynamics in axons and dendrites. Nat. Rev. Neurosci. 2009, 10:319-332.
22. Embi N., et al. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 1980, 107:519-527.
23. Cantuti Castelvetri L., et al. The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors. J. Neurosci. 2013, 33:10048-10056.
24. Chen S., et al. Serotonin stimulates mitochondrial transport in hippocampal neurons. Mol. Cell. Neurosci. 2007, 36:472-483.
25. Dolma K., et al. Presenilin influences glycogen synthase kinase-3 beta (GSK-3β) for kinesin-1 and dynein function during axonal transport. Hum. Mol. Genet. 2014, 23:1121-1133.
26. Morfini G., et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 2002, 21:281-293.
27. Weaver C., et al. Endogenous GSK-3/shaggy regulates bidirectional axonal transport of the amyloid precursor protein. Traffic 2013, 14:295-308.
28. Gao F.J., et al. GSK-3β phosphorylation of cytoplasmic dynein reduces Ndel1 binding to intermediate chains and alters dynein motility. Traffic 2015, 16:941-961.
29. Decker H., et al. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3β in primary cultured hippocampal neurons. J. Neurosci. 2010, 30:9166-9171.
30. Pigino G., et al. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 2003, 23:4499-4508.
31. McKenney R.J., et al. LIS1 and NudE induce a persistent dynein force-producing state. Cell 2010, 141:304-314.
32. Kawano Y., et al. CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation. Mol. Cell. Biol. 2005, 25:9920-9935.
33. Arimura N., et al. Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27. Dev. Cell 2009, 16:675-686.
34. Lovestone S., et al. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 1994, 4:1077-1086.
35. Cuchillo-Ibanez I., et al. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J. 2008, 22:3186-3195.
36. Lee S., et al. Divergent and convergent roles for kinases and phosphatases in neurofilament dynamics. J. Cell Sci. 2014, 127:4064-4077.
37. Shaul Y.D., Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 2007, 1773:1213-1226.
38. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. 2012, 66:105-143.
39. Li L., et al. Ionizing radiation causes increased tau phosphorylation in primary neurons. J. Neurochem. 2014, 131:86-93.
40. Newbern J.M., et al. Specific functions for ERK/MAPK signaling during PNS development. Neuron 2011, 69:91-105.
41. Vagnoni A., et al. Phosphorylation of kinesin light chain 1 at serine 460 modulates binding and trafficking of calsyntenin-1. J. Cell Sci. 2011, 124:1032-1042.
42. Mitchell D.J., et al. Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport. J. Neurosci. 2012, 32:15495-15510.
43. Vagnoni A., et al. Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production. Hum. Mol. Genet. 2012, 21:2845-2854.
44. Heerssen H.M., et al. Dynein motors transport activated Trks to promote survival of target-dependent neurons. Nat. Neurosci. 2004, 7:596-604.
45. Perlson E., et al. Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase. J. Mol. Biol. 2006, 364:938-944.
46. Moran C.M., et al. Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity. Brain Res. Mol. Brain Res. 2005, 134:338-344.
47. Plotnikov A., et al. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta 2011, 1813:1619-1633.
48. Morfini G.A., et al. Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS ONE 2013, 8:e65235.
49. Guo L., et al. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons. PLoS ONE 2013, 8:e54914.
50. Klinedinst S., et al. Independent pathways downstream of the Wnd/DLK MAPKKK regulate synaptic structure, axonal transport, and injury signaling. J. Neurosci. 2013, 33:12764-12778.
51. Stevenson A., et al. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neurosci. Lett. 2009, 454:161-164.
52. Miller C.C., et al. Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life Sci. 2002, 59:323-330.
53. Ackerley S., et al. p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 2004, 26:354-364.
54. Koch P., et al. Inhibitors of c-Jun N-terminal kinases: an update. J. Med. Chem. 2015, 58:72-95.
55. Morfini G., et al. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 2006, 9:907-916.
56. Morfini G.A., et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 2009, 12:864-871.
57. Stagi M., et al. Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J. 2006, 20:2573-2575.
58. Whitmarsh A.J. The JIP family of MAPK scaffold proteins. Biochem. Soc. Trans. 2006, 34:828-832.
59. Chiba K., et al. Quantitative analysis of APP axonal transport in neurons: role of JIP1 in enhanced APP anterograde transport. Mol. Biol. Cell 2014, 25:3569-3580.
60. Fu M.M., Holzbaur E.L. JIP1 regulates the directionality of APP axonal transport by coordinating kinesin and dynein motors. J. Cell Biol. 2013, 202:495-508.
61. Lindwall C., Kanje M. Retrograde axonal transport of JNK signaling molecules influence injury induced nuclear changes in p-c-Jun and ATF3 in adult rat sensory neurons. Mol. Cell. Neurosci. 2005, 29:269-282.
62. Koushika S.P. 'JIP'ing along the axon: the complex roles of JIPs in axonal transport. Bioessays 2008, 30:10-14.
63. Willoughby E.A., et al. The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK. J. Biol. Chem. 2003, 278:10731-10736.
64. DeFuria J., Shea T.B. Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphorylated neurofilaments: roles of JNK and GSK-3β. Brain Res. 2007, 1181:74-82.
65. Lew J., et al. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 1992, 267:13383-13390.
66. Meyerson M., et al. A family of human cdc2-related protein kinases. EMBO J. 1992, 11:2909-2917.
67. Miller N., et al. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. J. Neurosci. 2015, 35:6038-6050.
68. Castro-Alvarez J.F., et al. Cyclin-dependent kinase 5 targeting prevents β-amyloid aggregation involving glycogen synthase kinase 3β and phosphatases. J. Neurosci. Res. 2015, 93:1258-1266.
69. Ratner N., et al. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. J. Neurosci. 1998, 18:7717-7726.
70. Morfini G., et al. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 2004, 23:2235-2245.
71. Goodwin P.R., et al. Cyclin-dependent kinase 5 regulates the polarized trafficking of neuropeptide-containing dense-core vesicles in Caenorhabditis elegans motor neurons. J. Neurosci. 2012, 32:8158-8172.
72. Pandey J.P., Smith D.S. A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J. Neurosci. 2011, 31:17207-17219.
73. Manser C., et al. Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene 2012, 31:2773-2782.
74. Manser C., et al. Cdk5/p35 phosphorylates lemur tyrosine kinase-2 to regulate protein phosphatase-1C phosphorylation and activity. J. Neurochem. 2012, 121:343-348.
75. Klinman E., Holzbaur E.L. Stress-induced CDK5 activation disrupts axonal transport via Lis1/Ndel1/Dynein. Cell Rep. 2015, 12:462-473.
76. Shea T.B., et al. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J. Cell Sci. 2004, 117:933-941.
77. Zhou J., et al. Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins. Life Sci. 2010, 86:532-537.
78. Lee S., et al. C-terminal neurofilament phosphorylation fosters neurofilament-neurofilament associations that compete with axonal transport. Cytoskeleton 2011, 68:8-17.
79. Holmgren A., et al. Charcot-Marie-Tooth causing HSPB1 mutations increase Cdk5-mediated phosphorylation of neurofilaments. Acta Neuropathol. 2013, 126:93-108.
80. Colin E., et al. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J. 2008, 27:2124-2134.
81. Chen S., et al. Dopamine inhibits mitochondrial motility in hippocampal neurons. PLoS ONE 2008, 3:1-15.
82. Pigino G., et al. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5907-5912.
83. Hiruma H., et al. Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells. J. Physiol. 2002, 543:85-97.
84. Ozsarac N., et al. Activation of protein kinase C inhibits retrograde transport of neurotrophins in mice. J. Neurosci. Res. 2003, 72:203-210.
85. Morfini G., et al. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2442-2447.
86. Wang X., et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011, 147:893-906.
87. Shea T.B., Lee S. Neurofilament phosphorylation regulates axonal transport by an indirect mechanism: a merging of opposing hypotheses. Cytoskeleton 2011, 68:589-595.
88. Hida T., et al. Semaphorin3A-induced axonal transport mediated through phosphorylation of Axin-1 by GSK3β. Brain Res. 2015, 1598:46-56.
89. Chua J.J., et al. Phosphorylation-regulated axonal dependent transport of syntaxin 1 is mediated by a Kinesin-1 adapter. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5862-5867.
90. Harrington A.W., Ginty D.D. Long-distance retrograde neurotrophic factor signalling in neurons. Nat. Rev. Neurosci. 2013, 14:177-187.
91. Perlson E., et al. Retrograde axonal transport: pathways to cell death?. Trends Neurosci. 2011, 33:335-344.
92. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999, 2:50-56.
93. Tortarolo M., et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 2003, 23:180-192.
94. Nguyen M.D., et al. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001, 30:135-147.
95. Zala D., et al. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum. Mol. Genet. 2008, 17:3837-3846.
96. Takach O., et al. Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons. Neurobiol. Aging 2015, 36:1378-1382.
97. Ramser E.M., et al. Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol. Biol. Cell 2013, 24:2494-2505.
98. Kanaan N.M., et al. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J. Neurosci. 2011, 31:9858-9868.
99. Shaw J.L., Chang K.T. Nebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signaling. PLoS Genet. 2013, 9:e1003792.
100. Vossel K.A., et al. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β. J. Cell Biol. 2015, 209:419-433.
101. Malik B., et al. Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2011, 20:1776-1786.
102. Kanaan N.M., et al. Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp. Neurol. 2013, 246:44-53.
103. Chico L.K., et al. Targeting protein kinases in central nervous system disorders. Nat. Rev. Drug Discov. 2009, 8:892-909.
104. Wang W., et al. Kinesin, 30 years later: recent insights from structural studies. Protein Sci. 2015, 24:1047-1056.
105. Carter A.P. Crystal clear insights into how the dynein motor moves. J. Cell Sci. 2013, 126:705-713.
106. Urnavicius L., et al. The structure of the dynactin complex and its interaction with dynein. Science 2015, 347:1441-1446.
107. Melkonian K.A., et al. Mechanism of dynamitin-mediated disruption of dynactin. J. Biol. Chem. 2007, 282:19355-19364.
108. McKenney R.J., et al. Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes. Science 2014, 345:337-341.
109. Li C., et al. Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E. J. Neurosci. 2004, 24:6161-6170.
110. Dapper J.D., et al. Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy. Neurobiol. Dis. 2013, 59:26-37.